Literature DB >> 32343555

Elucidation of the Structure and Synthesis of Neuroprotective Low Molecular Mass Components of the Parawixia bistriata Spider Venom.

Yvonne M Forster1, Jennifer Leigh Green2, Apeksha Khatiwada2, José Luiz Liberato3, Poli Adi Narayana Reddy4, Joseph M Salvino4, Stefan Bienz1, Laurent Bigler1, Wagner Ferreira Dos Santos3, Andréia Cristina Karklin Fontana2.   

Abstract

The South American social spider Parawixia bistriata produces a venom containing complex organic compounds with intriguing biological activities. The crude venom leads to paralysis in termites and stimulates l-glutamate uptake and inhibits GABA uptake in rat brain synaptosomes. Glutamate is the major neurotransmitter at the insect neuromuscular junction and at the mammalian central nervous system, suggesting a modulation of the glutamatergic system by the venom. Parawixin1, 2, and 10 (Pwx1, 2 and 10) are HPLC fractions that demonstrate this bioactivity. Pwx1 stimulates l-glutamate uptake through the main transporter in the brain, EAAT2, and is neuroprotective in in vivo glaucoma models. Pxw2 inhibits GABA and glycine uptake in synaptosomes and inhibits seizures and neurodegeneration, and Pwx10 increases l-glutamate uptake in synaptosomes and is neuroprotective and anticonvulsant, shown in in vivo epilepsy models. Herein, we investigated the low molecular mass compounds in this venom and have found over 20 small compounds and 36 unique acylpolyamines with and without amino acid linkers. The active substances in fractions Pwx1 and Pwx2 require further investigation. We elucidated and confirmed the structure of the active acylpolyamine in Pwx10. Both fraction Pwx10 and the synthesized component enhance the activity of transporters EAAT1 and EAAT2, and, importantly, offer in vitro neuroprotection against excitotoxicity in primary cultures. These data suggest that compounds with this mechanism could be developed into therapies for disorders in which l-glutamate excitotoxicity is involved.

Entities:  

Keywords:  Acylpolyamine; EAAT1; EAAT2; GABA; MS/MS; Parawixin10 (Pwx10); UHPLC; high-resolution MS; neuroprotection; neurotransmitter

Mesh:

Substances:

Year:  2020        PMID: 32343555     DOI: 10.1021/acschemneuro.0c00007

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  3 in total

Review 1.  Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.

Authors:  Jennifer Leigh Green; Wagner Ferreira Dos Santos; Andréia Cristina Karklin Fontana
Journal:  Biochem Pharmacol       Date:  2021-09-24       Impact factor: 5.858

2.  Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2.

Authors:  Takafumi Kato; Tsukasa Kusakizako; Chunhuan Jin; Xinyu Zhou; Ryuichi Ohgaki; LiLi Quan; Minhui Xu; Suguru Okuda; Kan Kobayashi; Keitaro Yamashita; Tomohiro Nishizawa; Yoshikatsu Kanai; Osamu Nureki
Journal:  Nat Commun       Date:  2022-08-11       Impact factor: 17.694

3.  Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo.

Authors:  Michał Abram; Marcin Jakubiec; Katelyn Reeb; Mary Hongying Cheng; Robin Gedschold; Anna Rapacz; Szczepan Mogilski; Katarzyna Socała; Dorota Nieoczym; Małgorzata Szafarz; Gniewomir Latacz; Bartłomiej Szulczyk; Justyna Kalinowska-Tłuścik; Kinga Gawel; Camila V Esguerra; Elżbieta Wyska; Christa E Müller; Ivet Bahar; Andréia C K Fontana; Piotr Wlaź; Rafał M Kamiński; Krzysztof Kamiński
Journal:  J Med Chem       Date:  2022-08-19       Impact factor: 8.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.